MLAB: Mesa Labs EV/EBITDA Multiple

Corporate emblem and logo of Mesa Labs (MLAB)

Mesa Laboratories, Inc. (MLAB) generates revenue through the production of quality monitoring equipment, offering high-margin calibration systems and bioindicators. The company is considered a benchmark for reliability in the sterilization sector, enjoying unconditional trust from its B2B partners. This EV/EBITDA price chart shows the current multiple at 18.47. Growth prospects are supported by the tightening of global pharmaceutical regulations, which is expanding the customer pool.

Mesa Laboratories Corp. - MLAB Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/12/2026)

Summary analytical data breakdowns for mesalabs.com (MLAB)

- stock price and consensus target price:
Stock Quotes Mesa Labs Corp|MLAB - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Mesa Laboratories Corp.|MLAB - Company Buyout Price
- issuer book value statistics:
Book Value per Share Mesa Labs|MLAB - Company Net Assets|Market Cap to Net Assets Ratio mesalabs.com|MLAB - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Mesa Laboratories, Inc.|MLAB - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Mesa Labs|MLAB - Company Cumulative Debt|Debts to Book Capitalization Mesa Laboratories Corp.|MLAB - Company Long-Term Indebtedness|Company Short-Term Debts Mesa Labs|Quick Ratio mesalabs.com
- financial results and valuation multiples details:
MLAB - Net Income|Projected Future Earnings Mesa Laboratories, Inc.|MLAB - P/E Multiple|Future Price to Earnings Mesa Laboratories, Inc.|MLAB - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Mesa Laboratories Corp.|MLAB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Mesa Labs|MLAB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months mesalabs.com|MLAB - Net earnings per share change in current year|Expected earnings per share growth for next year Mesa Laboratories, Inc.
Initial company analysis:Mesa Labs Corp MLAB
Original product of mesalabs.com

The stable workforce at Mesa Laboratories, Inc. (MLAB) ensures long-term business reliability. The EV/EBITDA metric compares the total enterprise value, including debt, to operating income to determine the investment payback period. By analyzing the current EV/EBITDA level of Mesa Laboratories, Inc. (MLAB), an investor assesses the efficiency of capital management. Maintaining unique engineering competencies minimizes the risk of profit decline, supporting the stability of the business's fundamental valuation.

Competitor analysis for Mesa Laboratories, Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)